Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News CERo Therapeutics gets FDA boost for CER-1236, eyes breakthrough in AML cell therapy CERo Therapeutics secures FDA orphan drug status for CER-1236 in AML, advancing its novel CER-T immunotherapy platform. Read what this means for investors. byPallavi MadhirajuJune 17, 2025